Schrodinger and Takeda report new protease inhibitors for the treatment of SARS-CoV-2 June 11, 2024 ...
The dosing regimen for Zemaira is weight-based so the introduction of larger vial sizes reduces the number of reconstituted vials needed per dose. Zemaira (alpha 1-proteinase inhibitor [human]) is now ...
Pardes Biosciences Inc. has patented 3C-like proteinase (3CLpro; Mpro; nsp5) inhibitors (particularly HCoV-229E virus and/or SARS-CoV-2 Mpro inhibitors). They are reported to be potentially useful for ...
E.E. Farmer, C.A. Ryan, "Octadecanoid precursors of a jasmonic acid activate the synthesis of wound-inducible proteinase inhibitors," Plant Cell, 4:129-34, 1992. Clarence A. Ryan (Institute of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback